Biomonitoring in the era of the exposome

Environmental Health Perspectives

Volumn 125, Issue 4, 2017, Pages 502-510

  Dennis, Kristine K ^a   Marder, Elizabeth ^a   Balshaw, David M ^b   Cui, Yuxia ^b   Lynes, Michael A ^c   Patti, Gary J ^d   Rappaport, Stephen M ^e   Shaughnessy, Daniel T ^b   Vrijheid, Martine ^f   Barr, Dana Boyd ^a  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; LIFESPAN; MEDICAL RESEARCH; METABOLOMICS; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; SPATIAL SOIL VARIABILITY; TRADITIONAL MEDICINE; XENOBIOTIC METABOLISM; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; HUMAN GENOME; PROCEDURES;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MONITORING; GENOME, HUMAN; HUMANS;

EID: 85016818838     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP474     Document Type: Note

References (59)

1. Andra SS, Austin C, Arora M. 2015. Tooth matrix analysis for biomonitoring of organic chemical exposure: current status, challenges, and opportunities. Environ Res 142:387–406, doi: 10.1016/j. envres.2015.06.032.
2. Arora M, Bradman A, Austin C, Vedar M, Holland N, Eskenazi B, et al. 2012. Determining fetal manganese exposure from mantle dentine of deciduous teeth. Environ Sci Technol 46:5118–5125, doi: 10.1021/es203569f.
3. Baker SE, Olsson AO, Needham LL, Barr DB. 2005. High-performance liquid chromatography–tandem mass spectrometry method for quantifying sulfonylurea herbicides in human urine: reconsidering the validation process. Anal Bioanal Chem 383:963–976.
4. Barr DB, Wang RY, Needham LL. 2005. Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children’s Study. Environ Health Perspect 113:1083–1091, doi: 10.1289/ehp.7617.
5. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, et al. 2011. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila) 4:803–817, doi: 10.1158/1940–6207.
6. CDC (Centers for Disease Control and Prevention). 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Department of Health and Human Services, CDC. http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf [accessed 24 August 2015].
7. CDC. 2012. Chemical Selection, National Report on Human Exposure to Environmental Chemicals, Chemical Selection. http://www.cdc.gov/exposurereport/chemical_selection.html [accessed 7 October 2015].
8. CDC. 2015. Fourth National Report on Human Exposure to Environmental Chemicals Updated Tables. Department of Health and Human Services, CDC. http://www.cdc.gov/biomonitoring/pdf/FourthReport_UpdatedTables_Feb2015.pdf [accessed 1 September 2015].
9. CHEAR (Children’s Health Exposure Analysis Resource). 2016a. Lab Analysis Services. Targeted Analysis. https://chearprogram.org/access/lab-analysis-services/targeted [accessed 30 April 2016].
10. CHEAR. 2016b. Lab Analysis Services. Untargeted Analysis. Metabolomics. https://chearprogram. org/access/lab-analysis-services/untargeted/metabolomics [accessed 30 April 2016].
11. Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. 2015. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9:124, doi: 10.3389/fncel.2015.00124.
12. CORDIS Community Research and Development Information Service. 2014. EXPOSOMICS (Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe)http://cordis.europa.eu/result/rcn/146183_en.html [accessed 14 April 2016].
13. CORDIS. 2015. Periodic Report Summary 1 – HEALS (Health and Environment-wide Associations based on Large population Surveys). http://cordis.europa eu/result/rcn/171528_en.html [accessed 14 April 2016].
14. da Silva RR, Dorrestein PC, Quinn RA. 2015. Illuminating the dark matter in metabolomics. Proc Natl Acad Sci U S A 112(41):12549–12550, doi: 10.1073/pnas.1516878112.
15. Dennis KK, Auerbach SS, Balshaw DM, Cui Y, Fallin MD, Smith MT, et al. 2016. The importance of the biological impact of exposure to the concept of the exposome. Environ Health Perspect 124:1504–1510, doi: 10.1289/EHP140.
16. Go EP. 2010. Database resources in metabolomics: an overview. J Neuroimmune Pharmacol 5(1):18–30, doi: 10.1007/s11481-009-9157-3.
17. Go YM, Uppal K, Walker DI, Tran V, Dury L, Strobel FH, et al. 2014. Mitochondrial metabolomics using high-resolution Fourier-transform mass spectrometry. Methods Mol Biol 1198:43–73, doi: 10.1007/978-1-4939-1258-2_4.
18. Go YM, Walker DI, Liang Y, Uppal K, Soltow QA, Tran V, et al. 2015. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol Sci 148(2):531-543, doi: 10.1093/toxsci/kfv198.
19. Grigoryan H, Li H, Iavarone AT, Williams ER, Rappaport SM. 2012. Cys34 adducts of reactive oxygen species in human serum albumin. Chem Res Toxicol 25:1633-1642, doi: 10.1021/tx300096a.
20. Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115:455–462, doi: 10.1289/ehp.9783.
21. Ivanisevic J, Zhu ZJ, Plate L, Tautenhahn R, Chen S, O’Brien PJ, et al. 2013. Toward ‘omic scale metabolite profiling: a dual separation–mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal Chem 85:6876–6884, doi: 10.1021/ac401140h.
22. Johnson CH, Ivanisevic J, Benton HP, Siuzdak G. 2015. Bioinformatics: the next frontier of metabolomics. Anal Chem 87(1):147–156, doi: 10.1021/ac5040693.
23. Johnson JM, Yu T, Strobel FH, Jones DP. 2010. A practical approach to detect unique metabolic patterns for personalized medicine. Analyst 135(11):2864–2870, doi: 10.1039/c0an00333f.
24. Jones DP. 2016. Sequencing the exposome: a call to action. Toxicol Rep 3:29–45.
25. Kanehisa M. 2002. The KEGG database. Novartis Found Symp 247:91–101.
26. Kanehisa M, Goto S. 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28:27–30.
27. Kaufman AS, Zhou X, Reynolds MR, Kaufman NL, Green GP, Weiss LG. 2014. The possible societal impact of the decrease in U.S. blood lead levels on adult IQ. Environ Res 132:413–420, doi: 10.1016/j. envres.2014.04.015.
28. Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, et al. 2006. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 23(2):312–328.
29. Li S, Todor A, Luo R. 2015. Blood transcriptomics and metabolomics for personalized medicine. Comput Struct Biotechnol J 14:1–7, doi: 10.1016/j. csbj.2015.10.005.
30. LIPID MAPS (LIPID Metabolites and Pathways Strategy). 2015. Lipodomics Gateway. Resources Overview. http://www.lipidmaps.org/resources/resources.html [accessed 24 August 2015].
31. Lu C, Anderson LC, Morgan MS, Fenske RA. 1998. Salivary concentrations of atrazine reflect atrazine plasma levels in rats. J Toxicol Environ Health A 53:283–292.
32. Mahieu NG, Huang X, Chen YJ, Patti GJ. 2014. Credentialing features: a platform to benchmark and optimize untargeted metabolomic methods. Anal Chem 86:9583–9589, doi: 10.1021/ac503092d.
33. Marshall AG, Hendrickson CL. 2008. High resolution mass spectrometers. Annu Rev Anal Chem (Palo Alto Calif) 1:579–599, doi: 10.1146/annurev. anchem.1.031207.112945.
34. Miller GW, Jones DP. 2014. The nature of nurture: refining the definition of the exposome. Toxicol Sci 137(1):1–2, doi: 10.1093/toxsci/kft251.
35. NIEHS (National Institute of Environmental Health Sciences). 2015. Children’s Health Exposure Analysis Resource (CHEAR). https://www.niehs.nih.gov/research/supported/dert/programs/chear/index.cfm [accessed 1 September 2015].
36. Panuwet P, Hunter RE Jr, D’Souza PE, Chen X, Radford SA, Cohen JR, et al. 2016. Biological matrix effects in quantitative tandem mass spectrometry-based analytical methods: advancing biomonitoring. Crit Rev Anal Chem 46(2):93–105, doi: 10.1080/10408347.2014.980775.
37. Rager JE, Strynar MJ, Liang S, McMahen RL, Richard AM, Grulke CM, et al. 2016. Linking high-resolution mass spectrometry data with exposure and toxicity forecasts to advance high-throughput environmental monitoring. Environ Int 88:269–280, doi: 10.1016/j.envint.2015.12.008.
38. Rappaport SM. 2012. Biomarkers intersect with the exposome. Biomarkers 17:483–489, doi: 10.3109/1354750X.2012.691553.
39. Rappaport SM. 2016. Genetic factors are not the major causes of chronic diseases. PloS One 11(4):e0154387, doi: 10.1371/journal.pone.0154387.
40. Rappaport SM, Barupal DK, Wishart D, Vineis DP, Scalbert A. 2014. The blood exposome and its role in discovering causes of disease. Environ Health Perspect 122:769–774, doi: 10.1289/ehp.1308015.
41. Rappaport SM, Li H, Grigoryan H, Funk WE, Williams ER. 2012. Adductomics: characterizing exposures to reactive electrophiles. Toxicol Lett 213:83–90, doi: 10.1016/j.toxlet.2011.04.002.
42. Rappaport SM, Smith MT. 2010. Environment and disease risks. Science 330:460–461, doi: 10.1126/science.1192603.
43. Rosas LG, Eskenazi B. 2008. Pesticides and child neurodevelopment. Curr Opin Pediatr 20:191–197, doi: 10.1097/MOP.0b013e3282f60a7d.
44. Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, et al. 2005. METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747–751.
45. Soltow QA, Strobel FH, Mansfield KG, Wachtman L, Park Y, Jones DP. 2013. High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome. Metabolomics 9(1 suppl):S132–S143.
46. Southam AD, Lange A, Al-Salhi R, Hill EM, Tyler CR, Viant MT. 2014. Distinguishing between the metabolome and xenobiotic exposome in environmental field samples analyses by direct-infusion mass spectrometry based metabolomics and lipidomics. Metabolomics 10(6):1050–1058.
47. Spira A, Beane J, Schembri F, Liu G, Ding C, Gilman S, et al. 2004. Noninvasive method for obtaining RNA from buccal mucosa epithelial cells for gene expression profiling. Biotechniques 36:484–487.
48. Tautenhahn R, Cho K, Uritboonthai W, Zhu Z, Patti GJ, Siuzdak G. 2012. An accelerated workflow for untargeted metabolomics using the METLIN database. Nat Biotechnol 30:826–828, doi: 10.1038/nbt.2348.
49. Vrijheid M, Slama R, Robinson O, Chatzi L, Coen M, van den Hazel P, et al. 2014. The Human Early-Life Exposome (HELIX): project rationale and design. Environ Health Perspect 122:535–544, doi: 10.1289/ehp.1307204.
50. Wambaugh JF, Setzer RW, Reif DM, Gangwal S, Mitchell-Blackwood J, Arnot JA, et al. 2013. High-throughput models for exposure-based chemical prioritization in the ExpoCast project. Environ Sci Technol 47(15):8479–8488, doi: 10.1021/es400482g.
51. Wei R, Li G, Seymour AB. 2010. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Anal Chem 82(13):5527–5533, doi: 10.1021/ac100331b.
52. Wild CP. 2005. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14:1847–1850.
53. Wild CP. 2012. The exposome: from concept to utility. Int J Epidemiol 41:24–32, doi: 10.1093/ije/dyr236.
54. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. 2013. HMDB 3.0—the Human Metabolome Database in 2013. Nucleic Acids Res 41(database issue):D801–D807, doi: 10.1093/nar/gks1065.
55. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. 2009. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37(database issue):D603–D610, doi: 10.1093/nar/gkn810.
56. Yu T, Park Y, Li S, Jones DP. 2013. Hybrid feature detection and information accumulation using high-resolution LC-MS metabolomics data. J Proteome Res 12(3):1419–1427, doi: 10.1021/pr301053d.
57. Zhang J, Shen H, Xu W, Xia Y, Barr DB, Mu X, et al. 2014. Urinary metabolomics revealed arsenic internal dose-related metabolic alterations: a proof-of-concept study in a Chinese male cohort. Environ Sci Technol 48(20):12265–12274, doi: 10.1021/es503659w.
58. Zhang X, Sebastiani P, Liu G, Schembri F, Zhang X, Dumas YM, et al. 2010. Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium. Physiol Genomics 41:1–8, doi: 10.1152/physiolgenomics.00167.2009.
59. Zhou B, Xiao JF, Tuli L, Ressom HW. 2012. LC-MSbased metabolomics. Mol Biosyst 8(2):470–481, doi: 10.1039/c1mb05350g.